Form 4 holding
Chief People Officer
Apellis Pharmaceuticals, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- $1,306,808
- Report date
- 14 May 2026
- Price
- $19.39
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount